Publications by authors named "Jennifer Jess"

Claim this Profile
C
Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma.
Jennifer Jess, Katie M Sorensen, Elissa A Boguslawski, Matthew C Stout, Zachary B Madaj

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity.
Jennifer Jess, Bonnie Yates, Alina Dulau-Florea, Kevin Parker, Jon Inglefield

J Immunother Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotoxicity following CD19/CD28ζ CAR T-cells in children and young adults with B-cell malignancies.
Haneen Shalabi, Staci Martin, Bonnie Yates, Pamela L Wolters, Claire Kaplan, Jennifer Jess

Neuro Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials for chimeric antigen receptor T-cell therapy: lessons learned and future directions.
Brett A Schroeder, Jennifer Jess, Hari Sankaran, Nirali N Shah

Curr Opin Hematol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of a Pediatric Fruit and Vegetable Prescription Program on Child Dietary Patterns and Food Security.
Amy Saxe-Custack, Jenny LaChance, Jennifer Jess, Mona Hanna-Attisha

Nutrients· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preadmission Diet and Zip Code Influences the Pediatric Critical Care Clinical Course for Infants with Severe Respiratory Illness (  = 187).
Mara L Leimanis Laurens, Amina M Jaji, Jessica Montgomery, Jennifer Jess, Karen Ferguson, Jessica Parker

J Pediatr Intensive Care· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FLT Positron Emission Tomography (PET) is a Pharmacodynamic Marker for EWS-FLI1 Activity and Ewing Sarcoma.
Christy L Osgood, Mohammed N Tantawy, Nichole Maloney, Zachary B Madaj, Anderson Peck, Jennifer Jess

Sci Rep· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis